Caverject in Las Palmas de Gran Canaria, online
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription you can collect at a pharmacy in Las Palmas de Gran Canaria.
Consultation price. The medicine is paid at your pharmacy.
- Prescription only, if a doctor approves
- Collect at any EU pharmacy
- Full refund if not approved

Licensed EU doctors
Every case read by a registered doctor.
Reply in under 2 hours
On average, in writing, no video call.
Pay only if approved
Not approved? Refunded in full, automatically.
Rated excellent on Trustpilot
4.8 from 540+ independent reviews.
Valid across the EU
E-prescription accepted at EU pharmacies.
Caverject consultations in Las Palmas de Gran Canaria
What it is and how it works
Alprostadil is a prostaglandin E1 that directly dilates the blood vessels of the penis. It's considered when oral PDE5 inhibitors are ineffective or contraindicated.
It's administered as a urethral cream or an intracavernous injection, under medical instruction. Each route has its own efficacy and tolerability profile. Correct technique matters, and the doctor explains the protocol and the warning signs.
Who it is for
- Adult men whose erectile dysfunction is unsuited to, or not helped by, oral tablets
- Given as a cream at the tip of the penis, a urethral pellet, or an injection
Safety summary
An erection lasting 4 hours or more is priapism, and it is a medical emergency
Read the safety summaryOne consultation, one clear price
You pay for the doctor's consultation. If a prescription is issued, the medicine is paid at your own pharmacy.
- Consultation reviewed by an EU-licensed doctor
- Private follow-up in the in-app chat
- Full refund if the doctor does not approve
Sexual health
- Consultation reviewed by an EU-licensed doctor
- Electronic prescription if approved
- Private follow-up chat
Full refund if a review is not approved
Your questions answered
What is alprostadil and when is it used?
How is alprostadil administered?
More questions
What precautions apply?
Can it be combined with other ED treatments?
Does alprostadil work if you are not aroused?
Can I start alprostadil injections after an online consultation?
What should I do if an erection will not go down?
What should I do if I get side effects on Caverject?
Can I use Caverject with my other medicines?
What are the alternatives if Caverject is not right for me?
How does follow-up work while I use Caverject?
Can I get a consultation for Caverject from Las Palmas de Gran Canaria?
Is my sexual health consultation fully confidential?
What is the private electronic prescription and why is it valid across the EU?
How does Hi-Doctor work step by step?
How much does it cost and what does the price include?
How your doctor decides
Your answers
A licensed doctor reads your full questionnaire.
Medical judgement
The decision is clinical, never an algorithm.
Clear outcome
Approved with an e-prescription, or refunded in full.
Related medicines
Medicine information and safety
How does Caverject work?
A copy of prostaglandin E1. Alprostadil is chemically identical to prostaglandin E1, a signalling substance the body already makes. It is not swallowed. It is placed into or onto the penis itself, so it acts on the erectile tissue at the site rather than circulating through the whole body first.
Cavernosal muscle relaxes. The drug relaxes the smooth muscle of the corpora cavernosa, the two spongy cylinders that run the length of the penis, and widens the cavernosal arteries feeding them. Blood flow into the erectile tissue rises, and that increase in flow is what produces rigidity.
It does not need arousal. Because it acts on the tissue directly, alprostadil does not depend on the nitric oxide signal that sexual stimulation produces. In clinic testing it created erections on its own. That is the core difference from tablets, and it is also why an erection can outlast the encounter.
How to use Caverject
Get shown the technique first. Every form of alprostadil has to be demonstrated by a medical professional before you use it yourself. For the injection and the urethral pellet the first doses are given or supervised in a clinic, not at home, and that step cannot be skipped.
Empty your bladder first. Urinate before using the cream or the pellet. A moist urethra helps the medicine dissolve and spread. Do not urinate straight after the cream, because the dose can be washed out before it has had time to work.
Cream sits at the opening. Roll the single-dose container between your hands to warm it, hold the penis upright and squeeze the tip to widen the opening. Place the container at the opening without inserting it, push all the cream in, then hold the penis upright for about 30 seconds.
Pellet needs a stretch and roll. For the urethral pellet, stretch the penis upward to its full length, insert the applicator, press the button and withdraw it. Then roll the penis between your hands for at least 10 seconds so the medicine coats the urethral wall.
Stand or walk for ten minutes. After the pellet, sit or preferably stand or walk for about 10 minutes while the erection develops. An erection usually appears 5 to 10 minutes after the pellet and lasts roughly 30 to 60 minutes. The cream works in 5 to 30 minutes.
Injections rotate side and site. The injection goes into the upper side of the penis, along the third nearest the body, avoiding visible veins. Change both the side and the exact spot each time. Never straighten or reuse a bent needle, because needles can break.
Use a condom if pregnancy is possible. A condom is required if your partner is pregnant or could become pregnant, and it also reduces vaginal irritation, which is a reported reaction. Only latex condoms have been tested with the cream. Alprostadil is not a contraceptive and does not prevent infection.
Respect the frequency limits. The cream is used at most 2 to 3 times a week and once in 24 hours. Injections are at most once a day and three times a week. The pellet is at most 2 doses in 24 hours and 7 in 7 days.
Common side effects
Stop and get urgent medical help if (seek medical help immediately): An erection lasts 4 hours or more, which is priapism and a medical emergency that must not be left more than 6 hours, Penile pain will not settle, or you notice a new bend, lump or hard patch in the penis, You faint, feel close to fainting, or go dizzy with a sudden drop in blood pressure after a dose, You get chest pain, or sudden weakness, numbness or trouble speaking, Bleeding from the urethra will not stop, or there is blood in your urine, Hives, a spreading rash or swelling appear, which can signal an allergic reaction, A needle breaks and a fragment stays in the penis, which has needed surgical removal
Very common (very common (≥1/10)): Penile pain after intracavernosal injection, reported at least once by 30% of men and after 11% of injections, Penile pain after the urethral pellet, in most cases rated mild or moderate, Burning in the urethra after the urethral pellet
Common (common (≥1/100 to <1/10)): Burning, tingling, throbbing or numbness in the penis, with the cream, Redness, swelling, itching or general discomfort of the penis or genitals, with the cream, Urethral pain with the cream, or minor urethral bleeding with the pellet, An erection stronger or longer than expected, listed for all three forms, Peyronie's disease, penile fibrosis, angulation or fibrotic nodules, with the injection and the pellet, Bruising or a collection of blood at the injection site, Headache, dizziness, symptomatic low blood pressure and muscle spasms, with the pellet, Vaginal burning or itching in the partner, reported by about 6% of partners in the pellet studies, Skin rash, with the cream, Balanitis, inflammation of the head of the penis, with the cream
Uncommon (uncommon (≥1/1,000 to <1/100)): Prolonged erection or priapism, listed at this frequency for all three forms, Dizziness, fainting or a fall in blood pressure, listed for all three forms, Painful erection, excessive rigidity, or loss of sensation in the penis, Narrowing of the urethra, or inflammation of the urinary tract, with the cream, Painful or frequent urination, urgency, blood in the urine or urethral bleeding, Testicular or scrotal pain, swelling, redness or a lump, and pelvic or perineal pain, Phimosis, ejaculation problems, or erectile dysfunction reported as a reaction, Nausea, dry mouth, sweating, itching, rash, redness or a faster heartbeat, Itching of the vulva or vagina in the partner, with the cream, Widened pupils, extra heartbeats, a raised blood creatinine reading, or feeling weak
Rare (rare (≥1/10,000 to <1/1,000)): Urinary tract infection, listed at this frequency for the urethral pellet, Penile fibrosis, listed at this frequency for the urethral pellet
Very rare (very rare (<1/10,000)): Hives, known medically as urticaria, listed at this frequency for the urethral pellet
Frequency not known (not known (cannot be estimated from the available data)): Stroke, recorded in the injection product information as cerebrovascular accident, Reduced blood supply to the heart muscle, recorded as myocardial ischaemia
Do not use Caverject if
- You have sickle-cell disease or sickle-cell trait, multiple myeloma or leukaemia, all of which predispose to priapism
- You have another condition predisposing to priapism, such as thrombocythaemia, polycythaemia, a tendency to venous thrombosis, a hyperviscosity syndrome, or past recurrent priapism
- You have a penile implant
- Your penis is anatomically deformed, including angulation, curvature, cavernosal fibrosis, Peyronie's disease or severe hypospadias
- You have urethritis or balanitis, or for the pellet a narrowing of the lower urethra
- You are allergic to alprostadil or to any other ingredient in the product
- A doctor has advised that sexual activity is inadvisable, for example with severe heart disease or unstable heart or circulation problems
- You have orthostatic hypotension, or a history of heart attack or fainting, which rule out the cream
- Your partner is pregnant or could become pregnant and a condom will not be used
- You are already using another erectile dysfunction treatment, including a PDE5 inhibitor tablet or another injected agent
Medicines and substances that interact
- PDE5 inhibitor tablets (sildenafil, tadalafil, vardenafil): Never studied together; both act on blood vessels, so cardiovascular risk could add up Not used together; the prescriber keeps you on one treatment at a time
- Other injected erection agents (papaverine, phentolamine, thymoxamine): Raises the risk of priapism, a painful prolonged abnormal erection Not combined; alprostadil is prescribed on its own
- Blood pressure medicines and other vasodilators: Blood pressure can fall further, and the risk is higher in older men Prescribed with caution, with clear warning about dizziness and fainting
- Anticoagulants and antiplatelet drugs (warfarin, heparin): More bleeding after an injection, and more urethral bleeding or blood in the urine Prescriber weighs the bleeding risk and may rule out the injected route
- Sympathomimetics, decongestants and appetite suppressants: May reduce the effect of alprostadil, so a working dose can seem to fail Prescriber reviews the full medicine list before changing any dose
- Latex condoms: Only latex has been tested with the cream; other materials may be damaged by it Use a latex condom, which is required anyway if a partner could be pregnant
References
- Vitaros 3 mg/g cream: Summary of Product Characteristics electronic medicines compendium (emc), 2026
- Caverject Dual Chamber 20 micrograms: Summary of Product Characteristics electronic medicines compendium (emc), 2026
- MUSE 500 microgramos bastoncillo uretral: Ficha Técnica AEMPS, Spain, 2016
- Treatment of men with erectile dysfunction with transurethral alprostadil (MUSE Study Group) New England Journal of Medicine 336(1):1-7, 1997
- Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction (Alprostadil Study Group) New England Journal of Medicine 334(14):873-7, 1996
- EAU Guidelines on Sexual and Reproductive Health, limited update March 2025 European Association of Urology, 2025
- Alprostadil: authorised medicines register (Caverject, Virirec and alprostadil cream marketed; MUSE authorised but not marketed) AEMPS CIMA, Spain, 2026
- Alprostadil: Vitaros 300 microgrammes cream and Edex 10/20 microgrammes marketed, liste I, restricted reimbursement Base de données publique des médicaments, France, 2026
- Alprostadil products authorised in Ireland: Caverject 10 and 20 micrograms, Vitaros 3 mg/g cream medicines.ie, Irish medicines compendium, 2026
- Register of medicinal products: no ATC G04BE01 alprostadil product registered for erectile dysfunction Rejestr Produktów Leczniczych, Poland, 2026
- Nota 75: reimbursement of alprostadil by intracavernosal injection limited to defined neurological criteria AIFA, Gazzetta Ufficiale della Repubblica Italiana n. 7, 2017
- § 34 SGB V: medicines predominantly for erectile dysfunction excluded from statutory health insurance Bundesministerium der Justiz, Germany, 2026
- Regeling zorgverzekering: MUSE urethral stick 125 to 1000 micrograms listed on the Dutch medicines annex Wetten.overheid.nl, Netherlands, 2026
- Viagra (sildenafil): Summary of Product Characteristics, Annex I European Medicines Agency, 2025
- Cialis (tadalafil): Summary of Product Characteristics, Annex I European Medicines Agency, 2025
- Levitra (vardenafil): Summary of Product Characteristics, Annex I European Medicines Agency, 2024
- Alprostadil, human medicines with a currently valid German authorisation: Caverject and Caverject Impuls 10 and 20 micrograms (Pfizer Pharma GmbH plus parallel importers), Muse 500 and 1000 micrograms (Viatris Healthcare GmbH), Vitaros 300 micrograms/100 mg cream (The Simple Pharma Company Limited). The register publishes marketability, not whether a product is currently distributed. BfArM AMIce, public part, via PharmNet.Bund, Germany, 2026
- Alprostadilo: Caverject 0,01 and 0,02 mg/ml (Laboratórios Pfizer, Lda.) and Vitaros cream 0,3 mg/100 mg (Recordati Ireland Ltd.), each authorised with at least one marketed presentation INFARMED Infomed, Portugal, 2026
- Alprostadil: Caverject 10 and 20 micrograms and Vytaros 3 mg/g cream recorded as commercialised; Caverject Impuls 10 and 20 micrograms recorded as not commercialised FAGG-AFMPS medicines database, Belgium, 2026
- Alprostadil, ATC G04BE01: Muse 250, 500 and 1000 micrograms recorded as marketed; Caverject, Caverject Dual and Vitaros 3 mg/g cream authorised, with no marketing status published BASG Medikamente Info Austria, Arzneispezialitätenregister, 2026
Also available in
- Sevilla
- Málaga
- Córdoba
- Granada
- Jerez de la Frontera
- Almería
- Huelva
- Cádiz
- Jaén
- Marbella
- Zaragoza
- Huesca
- Teruel
- Oviedo
- Gijón
- Avilés
- Palma de Mallorca
- Ibiza
- Mahón
- Las Palmas de Gran Canaria
- Santa Cruz de Tenerife
- San Cristóbal de La Laguna
- Telde
- Arona
- Santander
- Toledo
- Valladolid
- Barcelona
- Valencia
- Alicante
- Mérida
- Vigo
- Santiago de Compostela
- Logroño
- Madrid
- Murcia
- Pamplona
- Bilbao
- Vitoria-Gasteiz
- San Sebastián
- Berlin
- Hamburg
- Munich
- Cologne
- Frankfurt
- Stuttgart
- Düsseldorf
- Leipzig
- Dortmund
- Essen
- Paris
- Marseille
- Lyon
- Toulouse
- Nice
- Nantes
- Montpellier
- Strasbourg
- Bordeaux
- Lille
- Rome
- Milan
- Naples
- Turin
- Palermo
- Genoa
- Bologna
- Florence
- Bari
- Catania
- Warsaw
- Krakow
- Łódź
- Wroclaw
- Poznań
- Gdansk
- Szczecin
- Bydgoszcz
- Amsterdam
- Rotterdam
- The Hague
- Utrecht
- Eindhoven
- Groningen
- Tilburg
- Almere
- Brussels
- Antwerp
- Ghent
- Charleroi
- Liège
- Bruges
- Namur
- Lisbon
- Porto
- Vila Nova de Gaia
- Amadora
- Braga
- Coimbra
- Bucharest
- Cluj-Napoca
- Iași
- Timișoara
- Constanta
- Craiova
- Athens
- Thessaloniki
- Patras
- Piraeus
- Prague
- Brno
- Ostrava
- Pilsen
- Budapest
- Debrecen
- Szeged
- Miskolc
- Vienna
- Graz
- Linz
- Salzburg
- Stockholm
- Gothenburg
- Malmö
- Uppsala
- Västerås
- Helsinki
- Espoo
- Tampere
- Vantaa
- Copenhagen
- Aarhus
- Odense
- Aalborg
- Dublin
- Cork
- Limerick
- Galway
- Sofia
- Plovdiv
- Varna
- Burgas
- Bratislava
- Košice
- Prešov
- Žilina
- Zagreb
- Split
- Rijeka
- Osijek
- Vilnius
- Kaunas
- Klaipėda
- Šiauliai
- Panevėžys
- Ljubljana
- Maribor
- Celje
- Riga
- Daugavpils
- Liepāja
- Jelgava
- Tallinn
- Tartu
- Narva
- Nicosia
- Limassol
- Larnaca
- Paphos
- Luxembourg City
- Esch-sur-Alzette
- Valletta
- Birkirkara
- Qormi
- Mosta
- Spain
- France
- Germany
- Italy
- Portugal
- Netherlands
- Belgium
- Ireland
- Poland
- Czechia
- Slovakia
- Hungary
- Romania
- Bulgaria
- Greece
- Cyprus
- Croatia
- Slovenia
- Austria
- Denmark
- Sweden
- Finland
- Estonia
- Latvia
- Lithuania
- Luxembourg
- Malta
Saying it is the first step
A doctor replies in under 2 hours on average.
Start consultationNo charge unless a doctor approves your treatment.Pay nothing if a doctor doesn't approve your treatment. Every consultation is fully refundable. How refunds work



